Original Research
Copyright ©The Author(s) 1997.
World J Gastroenterol. Dec 15, 1997; 3(4): 213-217
Published online Dec 15, 1997. doi: 10.3748/wjg.v3.i4.213
Figure 1
Figure 1 Immunostaining of a rat malignant nodule with anti-p21 monoclonal IgG2b antibody detected by the biotin-streptavidin method. Magnification × 10.
Figure 2
Figure 2 Immunostaining of a rat malignant foci with anti-p53 polyclonal antibody detected by the biotin-streptavidin method. Magnification × 40.
Figure 3
Figure 3 Immunostaining of a rat malignant foci with anti-bcl-2 polyclonal antibody detected by the biotin-streptavidin method. Magnification × 40.
Figure 4
Figure 4 Immunostaining of ultrastructure of a rat normal hepatocyte with anti-p21 IgG/colloidal gold (φ 10 nm) antibody. Magnification × 2000
Figure 5
Figure 5 Immunostaining of ultrastructure of a rat malignant hepatocyte with anti-p21 IgG/colloidal gold (φ 10 nm) antibody. Magnification × 2000.
Figure 6
Figure 6 Relationship between hepatocarcinoma malignancy and expression of oncogene proteins detected by immunofluorencence flow cytometry.